# Resolve Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resolve-therapeutics

- Industry: Biotechnology
- Headquarters: Kirkland, US
- Website: www.resolvebio.com
- Total disclosed funding: $7.8M
- Latest round: Series B (Nov 1, 2012)
- Investors on record: 3

## About

Resolve Therapeutics is based in US and operates as a biotechnology company which engages in research of biologic compounds for the patients suffering from lupus.

## Funding rounds

- Series B, Nov 1, 2012, $5.8M — Easton Capital Investment Group, WRF Capital, New Science Ventures
- Series A, May 17, 2011, $2M — Easton Capital Investment Group, New Science Ventures

## Investors

- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series A, Series B
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series B